If you need more lookups,
subscriptions start at $34 USD/month.
Greg Donoho Location
Indianapolis, IN, US
Greg Donoho Work
2020 -now Director - In Vivo Pharmacology @
2014 -2020 Director @ Eli Lilly and Company
2009 -2014 Principal Research Scientist @ Eli Lilly and Company
2003 -2009 Senior Research Scientist @ Eli Lilly and Company
2001 -2003 Principal Research Scientist @
2000 -2001 Group Leader @ Genometrix Genomics Incorporated
1997 -2000 Research Scientist @
Greg Donoho Education
Stanford University
PhD (Biochemistry)
1989-1996
Purdue University
BS (Biochemistry)
1985-1989
Mt. Vernon Community School Corporation 1981-1985
Greg Donoho Skills
Drug Development
Translational Research
Biomarkers
Preclinical models
Drug Discovery
Oncology
In Vitro
Assay Development
Biochemistry
Biotechnology
Cell
Cell Biology
Cell Culture
Clinical Development
Clinical Trials
Drug Design
High Throughput Screening
Translational Medicine
In Vivo
Immunology
Life Sciences
Molecular Biology
Lifesciences
Monoclonal Antibodies
Pharmacology
Pharmaceutical Industry
Greg Donoho Summary
Greg Donoho, based in Indianapolis, IN, US, is currently a Director - In Vivo Pharmacology at Loxo Oncology, Inc.. Greg Donoho brings experience from previous roles at Eli Lilly and Company and Pfizer. Greg Donoho holds a 1989 - 1996 PhD in Biochemistry @ Stanford University. With a robust skill set that includes Drug Development, Translational Research, Biomarkers, Preclinical models, Drug Discovery and more. Greg Donoho has 1 emails on RocketReach.
Looking for a different Greg Donoho?
Find contact details for 700 million professionals.